Invention Grant
- Patent Title: Glucosylceramide synthase inhibitors and therapeutic methods using the same
-
Application No.: US17076852Application Date: 2020-10-22
-
Publication No.: US11220479B2Publication Date: 2022-01-11
- Inventor: Scott D. Larsen , James A. Shayman , Kim Hutchings , Neil Moss , Qin Jiang , Nicholas Mayhew , Emily Freeman , Zohreh Sajjadi Hashemi
- Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Applicant Address: US MI Ann Arbor
- Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Current Assignee Address: US MI Ann Arbor
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07D205/04
- IPC: C07D205/04 ; C07D207/09 ; C07D405/12
Abstract:
Glucosylceramide synthase inhibitors and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
Public/Granted literature
- US20210122712A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS AND THERAPEUTIC METHODS USING THE SAME Public/Granted day:2021-04-29
Information query
